Headway (Clinics/Outpatient Services) logo

Headway (Clinics/Outpatient Services)

Current Valuation
$2.3B
As of July 12, 2024
Total Funding Raised
$332.3M
Last Round
Later Stage VC

$100.0M

Last Funding
Jul 2024

Funding date

Capital Efficiency
6.92x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Headway (Clinics/Outpatient Services) is currently valued at $2.3B as of July 12, 2024. The company has raised a total of $332.3M in funding.

Capital Efficiency

With a capital efficiency ratio of 6.92x, Headway (Clinics/Outpatient Services) has achieved a valuation that is 6.92 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.

Investment Perspective

Headway (Clinics/Outpatient Services)'s valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Headway (Clinics/Outpatient Services) Valuation Updates

Get notified when Headway (Clinics/Outpatient Services) raises new funding or valuation changes

What is Headway (Clinics/Outpatient Services) Worth in 2025?

As of 2025, Headway (Clinics/Outpatient Services) is valued at $2.3B, based on the company's Later Stage VC funding round in July 12, 2024. This valuation positions Headway (Clinics/Outpatient Services) as one of the leading private companies in the sector.

Headway (Clinics/Outpatient Services) Valuation History

Headway (Clinics/Outpatient Services)'s funding history demonstrates steady growth and investor confidence.

How Headway (Clinics/Outpatient Services) Valuation is Determined

Private company valuations like Headway (Clinics/Outpatient Services)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Headway (Clinics/Outpatient Services) Valuation FAQs

Is Headway (Clinics/Outpatient Services) profitable?

Headway (Clinics/Outpatient Services) has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Headway (Clinics/Outpatient Services)'s valuation compare to competitors?

Headway (Clinics/Outpatient Services) is valued at $2.3B, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Headway (Clinics/Outpatient Services) IPO?

Headway (Clinics/Outpatient Services) has not announced plans for an initial public offering. Until an IPO, investors can access Headway (Clinics/Outpatient Services) shares through secondary market platforms.